Also see: eBay, Hess: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
numbers were raised at Citigroup. Shares of AVGO are now seen reaching $45. Estimates also increased on higher wireless growth and buyback, Citigroup said. Buy rating.
Bank of America
estimates, target were cut at UBS. Shares of BAC now seen reaching $12. Estimates also lowered, on the second-quarter settlement and higher operating expenses, UBS said. Maintain Neutral rating.
Bank of America numbers were lowered at Morgan Stanley. Shares now seen reaching $19. Estimates were also cut, to match the company's new guidance, Morgan Stanley said. Overweight rating.
estimates lowered at Credit Suisse through 2013. Company is seeing lower sales at Citicorp, Credit Suisse said. Neutral rating.
estimates were increased through 2013 at Collins Stewart. Company is trying to turn its business around and is buying back more stock, Collins Stewart said. Neutral rating.
target was raised at ThinkEquity. Shares are now seen reaching $55. Provenge manufacturing facility has been approved by the FDA, ThinkEquity said. Buy rating.
price target was raised at UBS to $45 on higher EPS assumptions. Maintain Neutral rating
estimates were reduced through 2012 at Barclays. Company will likely face margin headwinds, Barclays said. Equal-weight rating and $46 price target.
numbers were increased through 2014 at Credit Suisse. DOE loans should help the company fuel future growth, Credit Suisse said. Neutral rating and new $135 price target.
estimates were lowered through 2012 at Jefferies. Company is facing pressure from retailers and increased competition from Kellogg, Jefferies said. Hold rating and $40 price target.
numbers were increased through 2013 at Credit Suisse. Company is seeing better domestic sales trends, Credit Suisse said. Outperform rating and new $39 price target.
estimates were raised through 2012 at Citigroup. Stronger adoption of key products, Citigroup said. Maintain Buy rating and $82 price target.
Monsanto estimates, target were raised at Credit Suisse. Shares now seen reaching $68. Estimates were also increased, given better agriculture productivity earnings, Credit Suisse said. Neutral rating.
numbers were cut through 2012 at Jefferies. Channel checks suggest that the company could be hurt by a soft patch in the economy, Jefferies said. Buy rating and new $27 price target.
numbers were boosted at Jefferies. Shares are now seen reaching $39. Estimates were also upped, given positive demand trends, Jefferies said. Buy rating.
estimates, target were boosted at Canaccord Genuity. Shares are now seen reaching $72. Estimates were also upped, given better smartphone demand, Canaccord said.
numbers were lowered through 2012 at Barclays. Company is facing specific problems, Barclays said. Equal-weight rating and new $34 price target.
Shaw Group estimates, target lowered at UBS. Shares now seen reaching $37. Estimates also cut to reflect a slower ramp in E&C and nuclear revenues and margins, UBS said. Buy rating.
End of report
This article was written by a staff member of TheStreet.